The alphaNAC transcriptional coregulator as a downstream effector of PTH action in bone
The alphaNAC transcriptional coregulator as a downstream effector of PTH action in bone
批准号:
237885
负责人:
St-Arnaud Ren
金额:
$45.69万
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2011
资助国家:
加拿大
项目状态:
已结题
起止时间:
2011-09-01 至 2016-09-01
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Osteoporosis, the most prevalent metabolic bone disease, affects the elderly. Daily subcutaneous injection ('intermittent treatment') with human parathyroid hormone (PTH) (Teriparatide or Fortéo®) is the only approved treatment for increasing bone mass in
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Compounds blocking FIAT activity increase osteogenesis
-
批准号:418144
-
项目类别:Operating Grants
-
资助金额:$36.22万
-
财政年份:2020
-
负责人:St-Arnaud Ren
-
依托单位:
The alphaNAC transcriptional coregulator as a downstream effector of PTH action in bone
-
批准号:219745
-
项目类别:Operating Grants
-
资助金额:$7.29万
-
财政年份:2010
-
负责人:St-Arnaud Ren
-
依托单位: